Theratechnologies Inc - Company Profile
Powered by
All the data and insights you need on Theratechnologies Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Theratechnologies Inc Strategy Report
- Understand Theratechnologies Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Theratechnologies Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP4069309A4 | Search Report | Sortilin-bindende konjugatverbindungen, zusammensetzungen und deren verwendung zur behandlung von krebs | A61K31/12; A61K31/337; A61K31/704; A61K47/26; A61K47/64; A61K9/0019; A61K9/08; A61P35/00; C07K14/47; C07K14/70571; C07K14/78; C07K2319/33 | March 27, 2024 |
EP4297795A1 | Application | Verfahren und sortilinbindende konjugatverbindungen zum targeting von krebsstammzellen | A61K31/337; A61K47/64; A61K51/088; A61P35/00; C07K14/705; C07K7/083 | January 03, 2024 |
KR1020230167033A | Application | 암 줄기 세포를 표적화하기 위한 방법 및 소르틸린 결합 접합체 화합물 | A61K31/337; A61K47/64; A61K51/088; A61P35/00; C07K14/705; C07K7/083 | December 07, 2023 |
US20230270865A1 | Application | Low-dose pharmaceutical compositions of ghrh analogs and uses thereof | A61K47/40; A61P3/06; A61K47/26; A61K38/25; C07K14/60; A61K9/0019; A61P3/00; Y02A50/30; A61P3/04; A61K9/19 | August 31, 2023 |
EP4175661A1 | Application | Compositions pharmaceutiques à faible dose d'analogues de ghrh, et leurs utilisations | A61K38/25; A61K47/22; A61K47/26; A61K47/40; A61K9/0019; A61K9/19; A61P3/00; A61P3/04; A61P3/06; C07K14/60; Y02A50/30 | May 10, 2023 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer